Cite Filings / ACRV / 0000950170-24-048671

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Acrivon Therapeutics, Inc. Filed 2024-04-26 Acc 0000950170-24-048671

Documents 1

DEF 14A Proxy Statement , 2024_proxy_statement.htm

Around this filing

2025-04-25 DEF 14A Proxy Statement
2024-04-26 ARS Annual Report to Security Holders
2024-04-26 DEFA14A Proxy Materials
2024-04-26 DEF 14A Proxy Statement
2024-04-24 CORRESP Correspondence Between Filers and SEC Staff
2024-04-24 8-K Results of operations · Regulation FD disclosure · Other events
2023-05-01 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading 2024_proxy_statement.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…